CS
VIE

Credit Suisse’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Credit Suisse’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,735
Closed -$602K – 4703
2020
Q4 		$602K Sell
16,735
-18,437
-52% -$646K ﹤0.01% 3692
2020
Q3 		$987K Buy
35,172
+19,476
+124% +$689K ﹤0.01% 2942
2020
Q2 		$680K Buy
+15,696
New +$711K ﹤0.01% 3139

Credit Suisse's VIE Position: Q1 2021 in Review

Credit Suisse sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 16,735 shares — an estimated $602K sold.

Credit Suisse first reported a position in VIE in Q2 2020 and held it in 3 quarters. The position peaked at $987K in Q3 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

  • Credit Suisse reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Credit Suisse sold 16,735 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $602K.
  • Credit Suisse first reported a position in Viela Bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Credit Suisse's Viela Bio, Inc. Common Stock position peaked at $987K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.